US2010069609A1PendingUtilityA1
Chemical methods and apparatus
Est. expiryJun 21, 2026(expired)· nominal 20-yr term from priority
Inventors:Erik Arstad
C07K 14/78B01J 2219/00822A61K 51/088A61K 51/0453C07K 14/75B01J 2219/0086B01J 2219/00873B01J 2219/00831B01J 19/0093C07K 1/13
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to methods and apparatus for labelling a biologically active vector such as a peptide with reporter moiety such as a radionuclide. The methods comprise reaction of a compound of formula (I) with a compound of formula (II): R*-L2-N3 (II) or, a compound of formula (III) with a compound of formula (IV) wherein: L1, L2, L3, and L4 are each Linker groups; R* is a reporter moiety; in a narrow bore copper vessel. Microfluidic devices for performing the methods of the invention are also claimed.
Claims
exact text as granted — not AI-modified1 . A method for labelling a vector comprising reaction of a compound of formula (I) with a compound of formula (II):
or,
a compound of formula (III) with a compound of formula (IV)
wherein:
L1, L2, L3, and L4 are each Linker groups;
R* is a reporter moiety;
to give a conjugate of formula (V) or (VI) respectively:
wherein L1, L2, L3, L4, and R* are as defined above;
characterised in that the reaction is performed in a narrow bore copper vessel.
2 . A method according to claim 1 wherein R* comprises a radionuclide.
3 . A method according to claim 1 wherein R* comprises a positron-emitting radionuclide, preferably 11 C or 18 F.
4 . A method according to claim 1 wherein the vector is a peptide, protein, hormone, cell, bacterium, virus, or small drug-like molecule, most suitably a peptide.
5 . A method according to claim 1 wherein the vector is Arg-Gly-Asp peptide or an analogue thereof.
6 . A method according to claim 1 wherein the vector is a peptide comprising the fragment:
7 . A method according to claim 1 wherein the vector is the peptide of formula (A):
wherein X 7 is either —NH 2 or
wherein a is an integer of from 1 to 10, preferably a is 1.
8 . Microfluidic device for performing a method according to claim 1 characterised in that said device comprises a device body defining a first apperture, a second apperture, and at least one elongate microfluidic passageway in fluid communication therebetween wherein at least a portion of the microfluidic passageway is defined by a metallic copper portion of the device body.
9 . Microfluidic device according to claim 8 wherein the device body defining the at least one microfluidic passageway is formed from metallic copper.
10 . Microfluidic device according to claim 8 wherein the device body further comprises a base portion and a cover portion defining said first apperture, second apperture, and at least one elongate microfluidic passageway in fluid communication therebetween.
11 . Microfluidic device according to claim 10 wherein the microfluidic passageway comprises a channel formed in either the base portion or the cover portion or in both thereof in overlying registry.
12 . Microfluidic device for performing a method according to claim 1 characterised in that said device comprises a device body defining a first apperture, a second apperture, and at least one elongate microfluidic passageway in fluid communication therebetween wherein at least a portion of the microfluidic passageway is defined by a metallic copper portion of the device body wherein the microfluidic passageway contains a compound of formula (I), (II), (III), or (IV) as defined in any of claim 1 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.